https://interhospi.com/wp-content/uploads/sites/3/2025/04/FERNO_Power-X2_Power-F2_Connect.jpg
529
1000
panglobal
https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png
panglobal2025-04-21 08:00:582025-04-16 10:11:36Ferno unveils next-generation powered EMS transport system
https://interhospi.com/wp-content/uploads/sites/3/2025/04/Sapien_M3-scaled.jpg
1440
2560
panglobal
https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png
panglobal2025-04-17 08:00:522025-04-16 09:53:54Edwards receives CE mark for transfemoral mitral valve replacement system
https://interhospi.com/wp-content/uploads/sites/3/2025/04/Womed_Leaf.gif
338
600
panglobal
https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png
panglobal2025-04-16 09:46:542025-04-16 09:46:54Womed introduces first intrauterine adhesion barrier film to European market
https://interhospi.com/wp-content/uploads/sites/3/2025/04/philips-remote-scan.jpg
394
700
panglobal
https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png
panglobal2025-04-16 09:41:112025-04-16 09:41:11Philips receives EU MDR certification for remote scanning solution
https://interhospi.com/wp-content/uploads/sites/3/2025/04/Baxter_Hemopatch.jpg
637
955
panglobal
https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png
panglobal2025-04-16 09:35:032025-04-16 09:35:03Baxter introduces room temperature Hemopatch for surgical bleeding control
https://interhospi.com/wp-content/uploads/sites/3/2025/04/liver.jpeg
518
922
panglobal
https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png
panglobal2025-04-11 08:00:212025-04-07 15:41:55AI tool for NASH diagnosis receives first EMA qualification
https://interhospi.com/wp-content/uploads/sites/3/2025/04/Beckman-Coulter_Basophil-Activation-Test.jpg
387
750
panglobal
https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png
panglobal2025-04-09 11:32:322025-04-09 11:32:32Beckman Coulter introduces ground-breaking next-gen basophil activation test for allergy research
https://interhospi.com/wp-content/uploads/sites/3/2025/03/fujifilm-healthcare-europe-eg-740ut-ultrasonic-endoscope.png
300
600
panglobal
https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png
panglobal2025-03-31 12:37:472025-03-31 12:37:47Fujifilm launches advanced interventional ultrasonic endoscope across Europe
As artificial intelligence becomes increasingly sophisticated in mimicking human interaction, psychologists warn that intimate relationships with AI companions present significant ethical challenges ranging from disruption of human bonds to potential manipulation and exploitation of vulnerable users.
A comprehensive evaluation of a green social prescribing programme in northern England has demonstrated that connecting people with nature-based activities can significantly improve mental health outcomes within just 12 weeks. The findings, published 16 April 2025 in Health & Social Care in the Community, highlight the potential for nature-based interventions to serve as effective therapeutic […]
Sleep works as the body’s natural reset – a time for the mind to recharge and the body to restore itself. Yet, for millions suffering from obstructive sleep apnea (OSA), restful sleep remains elusive. Instead of renewal, they endure interrupted breathing and fragmented rest, leading to an increased risk of serious health issues.
As global health authorities tackle with a host of established infectious disease threats, a previously obscure virus is steadily expanding its reach beyond its traditional Amazonian stronghold. Oropouche virus, first identified in Trinidad and Tobago in 1955, has emerged as a significant public health concern across South America and the Caribbean, with recent outbreaks reported […]
interhospi.com
The online source of medical device information connecting healthcare professionnals to global vendors.
clinlabint.com
Clinical Laboratory International (CLI) has been at the forefront of communication in the clinical chemistry and diagnostics
market for over 40 years.
cars-int.org
Founded in 1983, CARS is focusing on research and development on novel algorithms and systems and their applications in radiology and surgery.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
Antibiotics in infancy linked to higher asthma and food allergy risk
, /in E-News, pharmacology, Research /by panglobalA large-scale study from Rutgers Health has found that repeated antibiotic exposure in children under two years of age is associated with a significantly higher risk of developing asthma, food allergies and hay fever later in childhood. The research, involving over one million children, demonstrates that antibiotics may disrupt the digestive microbiome during a critical […]
Adolescent sleep patterns significantly impact brain development and cognitive ability
, /in Adolescent Health, E-News, Neurology /by panglobalIn a pioneering study examining the relationship between sleep patterns and adolescent brain development, researchers have revealed that young people who sleep longer and go to bed earlier show improved brain structure, neural connectivity, and cognitive performance compared to their peers with later bedtimes and shorter sleep duration – though even the best sleepers fall […]
Childhood bacterial toxin exposure fuels young-onset colorectal cancer epidemic
, /in E-News, Oncology, Paediatrics /by panglobalA bacterial toxin produced by certain strains of Escherichia coli may explain the alarming increase in colorectal cancer among young adults, according to groundbreaking research published in Nature. The study reveals that colibactin exposure in early childhood creates distinct genetic signatures that significantly increase cancer risk before age 50.
AI tool for NASH diagnosis receives first EMA qualification
AIM NASH, /in Diagnostic tests, E-News, Product News /by panglobalThe European Medicines Agency has qualified the first artificial intelligence-based tool designed to evaluate liver biopsies in patients with metabolic dysfunction-associated steatohepatitis (MASH). The system, called AIM-NASH, helps pathologists assess disease severity and reduce variability in histological scoring, with the aim of accelerating drug development for this increasingly common liver condition.